| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |